|Chennai||Rs. 24020.00 (-0.17%)|
|Mumbai||Rs. 25020.00 (0.28%)|
|Delhi||Rs. 24450.00 (0%)|
|Kolkata||Rs. 24600.00 (-0.32%)|
|Kerala||Rs. 24050.00 (0%)|
|Bangalore||Rs. 24160.00 (-0.17%)|
|Hyderabad||Rs. 24030.00 (-0.12%)|
Higher sales helped Johnson & Johnson post a much bigger fourth-quarter profit that a year ago, when a slew of charges depressed results.
The New Brunswick, N.J., company says net income was $2.57 billion, or 91 cents per share, up from $218 million, or 8 cents per share, in 2011's fourth quarter.
Excluding about $800 million in one-time acquisition and litigation charges, earnings in the latest quarter would have been $3.38 billion, or $1.19 per share. That beat the expectation of analysts by 2 cents per share.
The maker of prescription drugs, consumer health products and medical devices says revenue totaled $17.56 billion, just shy of analysts' average estimate of $17.69 billion.
J&J said it expects full-year profit of $5.35 to $5.45 per share. Analysts had expected $5.49.